Colgate-Palmolive reported its Q3 2024 earnings, surpassing analyst expectations. The company achieved an adjusted EPS of $0.91, higher than the estimated $0.88, and reported revenue of $5.03 billion, exceeding the forecasted $5.01 billion. The revenue marked a 2.4% year-over-year increase. Colgate-Palmolive also provided updated guidance for the fiscal year, anticipating organic sales growth between 7% and 8%, and net sales growth between 3% and 5%. The CEO highlighted that this quarter marks the sixth consecutive period of gross margin expansion, along with growth in operating profit, net income, and EPS. Organic sales grew by 6.8%, driven by a volume increase of 3.7% and pricing gains of 3.1%. Despite the positive earnings, Colgate-Palmolive's stock saw a decline of 3% in pre-market trading.